Phase1, Biostatistics Trainee

About your role

Phase1 is Orion's paid trainee programme designed for university students, bringing together a large and diverse group of talents from various fields every year. In addition to interesting summer jobs with meaningful projects, the programme offers a variety of events, networking opportunities with other Phase1 Trainees and Orion employees, as well as small group mentoring to support your career Could this be the first research phase of your Orion career? You can find more information about the Phase1 trainee programme on Orion's website.

Join Orion Pharma's Phase 1 Program as a Biostatistics Trainee in summer 2026 and gain hands-on experience in clinical R&D, applying modern statistical methods like Bayesian analysis and network meta-analysis. This full-time traineeship is ideal for statistics students eager to contribute to real-world pharmaceutical research while advancing their academic goals.

The Biostatistics Trainee position is part of Orion Pharma's Phase 1 Program, a structured summer traineeship for university students. The purpose of the role is to support Orion's Clinical Research & Development activities by contributing to statistical planning, analysis, and interpretation of clinical trial data. This aligns with Orion's mission to develop innovative treatments that improve quality of life.

The trainee will work on real-world clinical R&D projects, with opportunities to explore modern statistical methods such as Bayesian statistics and network meta-analysis, and potentially align their work with a Master's thesis.

The position reports to a Senior Biostatistician within Orion's Clinical R&D team. Location can be Espoo, Turku, or Kuopio.

Your key responsibilities

• Assist in the design and analysis of clinical trials across various development phases
• Apply statistical methods to support decision-making in clinical R&D
• Explore and implement Bayesian approaches and network meta-analysis techniques
• Contribute to documentation and reporting of statistical analyses
• Collaborate with biostatisticians, clinical scientists, data managers, and other stakeholders
• Support development of statistical tools and workflows
• Align project work with academic goals, such as a Master's thesis

What we offer

• A meaningful summer traineeship in a leading pharmaceutical company
• Mentorship from experienced biostatisticians
• Opportunities to work on real clinical development projects
• Exposure to modern statistical methods and tools
• Possibility to align work with academic goals (e.g., Master's thesis)
• A collaborative and flexible working culture

At Orion, your work creates true impact and well-being for our customers, patients and society at large. ​Our culture of friendliness, respect, mutual appreciation and diversity creates a safe working environment where you can strive for excellence. We offer a wealth of career paths and development opportunities that support the development of innovative solutions and improving the quality of life.

Please visit our website to find further information about our values and Orion as an employer 

Our expectations

• Ongoing Bachelor's or early Master's studies in statistics, biostatistics, or a related field
• Basic understanding of Bayesian statistics and/or network meta-analysis
• Familiarity with statistical software such as R, SAS, or Python
• Good communication skills in English
• Ability to work independently and collaboratively
• Interest in applying statistical methods in pharmaceutical R&D
• Self-motivated, adaptable, and eager to learn

How to apply and additional information
Please apply as soon as possible, but no later than February 1st, 2026. We might start interviewing candidates during the application time, so please ensure that we have your application as soon as possible

Our Phase1 trainees will be paid a monthly salary of €2370–2625, depending on the number of completed study credits. In addition, the Phase1 trainees are eligible to various employee benefits offered by the company.

Contact for questions: Toni Sarapohja, Head of Biostatistics,
Preliminary interview schedule: 1st round ; 2nd round

If you would like to know more about the application process and timelines, please visit our website. 
Welcome to build well-being with us next summer 2026

Approved medical examination which also includes drug testing is required prior to the employment. We will also carry out a security clearance prior to the employment for the selected person.

Unit description

Orion's pharmaceutical innovations are created within its R&D organization. We employ around 400 top professionals in the field of drug discovery and development. We work globally: in Espoo, Turku and Kuopio in Finland, in Nottingham in England and in New York, NY, USA. Orion R&D and the Innovative Medicines business division are dedicated to making a transformation to become a global player in the pain and oncology therapy areas.

#LI-DNI

Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.

We're home to more than 4,000 Orionees around the world, and we're proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.

Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.

We offer careers with a clear purpose: empowering people to live their lives to the fullest.

About Orion